Checkpoint Therapeutics (CKPT) News Today $3.38 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is HC Wainwright's Estimate for CKPT FY2024 Earnings?November 20 at 2:25 AM | americanbankingnews.comFY2024 Earnings Forecast for CKPT Issued By HC WainwrightCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Free Report) - Equities research analysts at HC Wainwright cut their FY2024 earnings per share estimates for shares of Checkpoint Therapeutics in a research note issued on Thursday, November 14th. HC Wainwright analyst J. Pantginis now forecasts that tNovember 18 at 2:30 AM | marketbeat.comCheckpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023)November 16, 2024 | uk.finance.yahoo.comCheckpoint Therapeutics, Inc: Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 14, 2024 | finanznachrichten.deOptimistic Buy Rating for Checkpoint Therapeutics Driven by Strong Financial Position and Strategic CollaborationsNovember 14, 2024 | markets.businessinsider.comCheckpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA DateNovember 14, 2024 | seekingalpha.comWest Virginia State Police to hold DUI Checkpoint in Mercer CountyNovember 14, 2024 | msn.comCheckpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 12, 2024 | globenewswire.comCheckpoint Therapeutics, Inc. (NASDAQ:CKPT) Sees Large Increase in Short InterestCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 4,610,000 shares, a growth of 5.3% from the September 30th total of 4,380,000 shares. Based on an average daily trading volume, of 459,900 shares, the days-to-cover ratio is presently 10.0 days. Approximately 12.3% of the company's shares are sold short.October 31, 2024 | marketbeat.comOvercoming Resistance to Checkpoint Inhibitor Cancer TherapyOctober 25, 2024 | forbes.comCheckpoint Therapeutics (NASDAQ:CKPT) Stock, Short Interest ReportOctober 8, 2024 | benzinga.comBodycam Footage Shows Influencer Therapist's 2023 DUI Arrest At NJ Town's Sobriety CheckpointOctober 4, 2024 | msn.comMetabolic reprogramming of T cells may enhance checkpoint inhibitor therapySeptember 26, 2024 | msn.comBuy Rating Justified by Promising Efficacy of Checkpoint’s Cosibelimab in Clinical TrialsSeptember 17, 2024 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Checkpoint Therapeutics (NASDAQ:CKPT)HC Wainwright restated a "buy" rating and set a $20.00 price objective on shares of Checkpoint Therapeutics in a research report on Monday.September 16, 2024 | marketbeat.comCheckpoint Therapeutics Presents Cosibelimab Longer-Term Results In Advanced CSCCSeptember 16, 2024 | markets.businessinsider.comCheckpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024September 16, 2024 | globenewswire.comCharlotte Airport Checkpoint C closing Thursday for constructionSeptember 6, 2024 | yahoo.comCheckpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comCLT Airport Checkpoint C closing, new American counters open in next step of expansionSeptember 4, 2024 | yahoo.comCCL Label Debuts Innovative RFID Solutions at Labelexpo 2024 with Checkpoint SystemsAugust 27, 2024 | tmcnet.comEMulate Therapeutics Inc. Announces Publication of Pre-Clinical Mouse Model Demonstrating Direct Evidence of Immune Checkpoint Receptor Knock-Down in a Mouse Glioblastoma ModelAugust 20, 2024 | businesswire.comCheckpoint Therapeutics files secondary offering of up to 5.9M sharesAugust 20, 2024 | msn.comVanguard Group Inc. Acquires 369,586 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)Vanguard Group Inc. grew its holdings in shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT - Free Report) by 67.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 917,894 shares of the comAugust 20, 2024 | marketbeat.comCheckpoint Therapeutics, Inc. (NASDAQ:CKPT) Short Interest UpdateCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Get Free Report) was the recipient of a large growth in short interest in July. As of July 31st, there was short interest totalling 4,230,000 shares, a growth of 7.4% from the July 15th total of 3,940,000 shares. Based on an average daily volume of 421,200 shares, the short-interest ratio is presently 10.0 days. Approximately 13.9% of the company's shares are short sold.August 19, 2024 | marketbeat.comBurbank Police to Conduct DUI Checkpoint on SaturdayAugust 16, 2024 | msn.comQ3 2024 Earnings Estimate for Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Issued By HC WainwrightCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Free Report) - HC Wainwright reduced their Q3 2024 earnings per share estimates for Checkpoint Therapeutics in a research note issued on Monday, August 12th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($0.51)August 15, 2024 | marketbeat.comFortress Biotech, Inc.: Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 14, 2024 | finanznachrichten.deIndividual investors account for 57% of Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) ownership, while public companies account for 9.8%August 14, 2024 | finance.yahoo.comCheckpoint Therapeutics, Inc: Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate UpdatesAugust 14, 2024 | finanznachrichten.deCheckpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate UpdatesAugust 12, 2024 | globenewswire.comCheckpoint Therapeutics Shares Rise After FDA Accepts Resubmission of CosibelimabJuly 25, 2024 | marketwatch.comCheckpoint Therapeutics Says FDA Accepted BLA Resubmission Of CosibelimabJuly 25, 2024 | markets.businessinsider.comCheckpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell CarcinomaJuly 25, 2024 | globenewswire.comGC Cell and Checkpoint Therapeutics Advance Collaborative Cancer ResearchJuly 15, 2024 | globenewswire.comCheckpoint Therapeutics, Inc. (NASDAQ:CKPT) Short Interest Down 6.1% in JuneCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Get Free Report) was the recipient of a large decrease in short interest in June. As of June 15th, there was short interest totalling 3,820,000 shares, a decrease of 6.1% from the May 31st total of 4,070,000 shares. Approximately 13.1% of the shares of the company are sold short. Based on an average daily trading volume, of 377,200 shares, the days-to-cover ratio is currently 10.1 days.July 3, 2024 | marketbeat.comCheckpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJuly 2, 2024 | globenewswire.comCheckpoint Therapeutics Announces Biologics License Application Resubmission for CosibelimabJuly 2, 2024 | globenewswire.comCheckpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO William Garrett Gray Sells 13,038 SharesJune 29, 2024 | insidertrades.comCheckpoint Therapeutics, Inc. (NASDAQ:CKPT) CFO Sells $26,858.28 in StockCheckpoint Therapeutics, Inc. (NASDAQ:CKPT - Get Free Report) CFO William Garrett Gray sold 13,038 shares of the business's stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $2.06, for a total value of $26,858.28. Following the sale, the chief financial officer now directly owns 672,186 shares in the company, valued at approximately $1,384,703.16. The sale was disclosed in a legal filing with the SEC, which is available through this link.June 28, 2024 | marketbeat.comCheckpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA ResubmissionJune 24, 2024 | globenewswire.comCHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 5, 2024 | globenewswire.comCKPT DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPTJune 3, 2024 | globenewswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)June 3, 2024 | businesswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointJune 3, 2024 | globenewswire.comCKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!June 3, 2024 | globenewswire.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CheckpointMay 31, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPTMay 30, 2024 | prnewswire.comCKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud LawsuitMay 30, 2024 | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPTMay 29, 2024 | prnewswire.com Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin CKPT Media Mentions By Week CKPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CKPT News Sentiment▼0.040.46▲Average Medical News Sentiment CKPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CKPT Articles This Week▼113▲CKPT Articles Average Week Get Checkpoint Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CKPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Leap Therapeutics News Today Oculis News Today AnaptysBio News Today Tectonic Therapeutic News Today Tourmaline Bio News Today Immunome News Today Annexon News Today ChromaDex News Today IGM Biosciences News Today ABIVAX Société Anonyme News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CKPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CKPT Stock Alerts